MARTHA LINDHORST: Open Payments
NPI 1619639366 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 23 payments from 12 companies in 2025. Trend: 2023 $426 · 2024 $615 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $87 |
| PFIZER INC. | 4 | $66 |
| Inspire Medical Systems, Inc. | 2 | $52 |
| Actelion Pharmaceuticals US, Inc. | 2 | $35 |
| Novo Nordisk Inc | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Astellas Pharma US Inc | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: INSPIRE, UBRELVY, OPSUMIT, MOUNJARO, ELIQUIS, VRAYLAR, Veozah, GEMTESA.
Industry payments across NE — which companies pay providers there.
